Cargando…
A novel FGF23 mutation in hyperphosphatemic familial tumoral calcinosis and its deleterious effect on protein O-glycosylation
BACKGROUND: Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare disease characterized by hyperphosphatemia and ectopic calcification, predominantly at periarticular locations. This study was performed to characterize the clinical profile of tumoral calcinosis and to identify gene mutation...
Autores principales: | Zuo, Qingyao, Yang, Weili, Liu, Baoyue, Yan, Dong, Wang, Zhixin, Wang, Hong, Deng, Wei, Cao, Xi, Yang, Jinkui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540505/ https://www.ncbi.nlm.nih.gov/pubmed/36213261 http://dx.doi.org/10.3389/fendo.2022.1008800 |
Ejemplares similares
-
Familial Hyperphosphatemic Tumoral Calcinosis
por: Saifuddin, Mohammad, et al.
Publicado: (2023) -
Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management
por: Boyce, Alison M., et al.
Publicado: (2020) -
A Cross‐Sectional Cohort Study of the Effects of FGF23 Deficiency and Hyperphosphatemia on Dental Structures in Hyperphosphatemic Familial Tumoral Calcinosis
por: Lee, Alisa E, et al.
Publicado: (2021) -
A rare disease: Familial hyperphosphatemic tumoral calcinosis
por: Akçay, Seçkin, et al.
Publicado: (2023) -
Hyperphosphatemic Tumoral Calcinosis With Pemigatinib Use
por: Puar, Akshan, et al.
Publicado: (2022)